Predicting the risk of coronary heart disease. I. The use of conventional risk markers.

Atherosclerosis

Volumn 213, Issue 2, 2010, Pages 345-351

  Dent, T H S ^a  

^a PHG FOUNDATION   (United Kingdom)

Author keywords

Conventional risk factors; Coronary heart disease; Genetics; Novel biomarkers; Risk prediction

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

CARDIOVASCULAR RISK; DISEASE CLASSIFICATION; ETHNICITY; FAMILY HISTORY; FRAMINGHAM MODEL; HUMAN; ISCHEMIC HEART DISEASE; MORTALITY; PRACTICE GUIDELINE; PREDICTIVE VALIDITY; PRIORITY JOURNAL; REVIEW; SCORING SYSTEM; SOCIAL STATUS;

CALIBRATION; COHORT STUDIES; CORONARY DISEASE; EUROPE; FEMALE; HEALTH SURVEYS; HUMANS; MALE; MASSACHUSETTS; MIDDLE AGED; RISK ASSESSMENT; RISK FACTORS;

EID: 78649749130     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.06.019     Document Type: Review

References (37)

1. Jackson R. Cardiovascular risk prediction: are we there yet?. Heart 2008, 94:1-3.
2. Lloyd-Jones D.M. Short-term versus long-term risk for coronary artery disease: implications for lipid guidelines. Curr Opin Lipidol 2006, 17(December (6)):619-625.
3. Justice A.C., Covinsky K.E., Berlin J.A. Assessing the generalizability of prognostic information. Ann Intern Med 1999, 130:515-524.
4. Kannel W.B., McGee D., Gordon T. A general cardiovascular risk profile: the Framingham Study. Am J Cardiol 1976, 38:46-51.
5. Anderson K.M., Wilson P.W.F., Odell M., Kannell W.B. An updated coronary risk profile: a statement for health professionals. Circulation 1991, 83:356-362.
6. Wilson P.W.F., D'Agostino R.B., Levy D., et al. Prediction of coronary heart disease using risk factor categories. Circulation 1998, 97:1837-1847.
7. Brindle P., Emberson J., Lampe F., et al. Predictive accuracy of the Framingham coronary heart risk score in British men: prospective cohort study. BMJ 2003, 327:1267-1270.
8. Fawcett T. An introduction to ROC analysis. Pattern Recognit Lett 2006, 27:861-874.
9. Luepker R.V. US trends. Coronary heart disease epidemiology 2005, Oxford University Press, Oxford. M. Marmot, P. Elliot (Eds.).
10. Brindle P., Beswick A., Fahey T., Ebrahim S. Accuracy and impact of risk assessment in the primary prevention of cardiovascular disease: a systematic review. Heart 2006, 92:1752-1759.
11. Eichler K., Puhan M.A., Steurer J., Bachmann L.M. Prediction of first coronary events with the Framingham score: a systematic review. Am Heart J 2007, 153:722-731.
12. Prediction of mortality from coronary heart disease among diverse populations: is there a common predictive function?. Heart 2002, 88:222-228. Diverse Populations Collaborative Group.
13. Brindle P.M., McConnachie A., Upton M.N., et al. The accuracy of the Framingham risk-score in different socioeconomic groups: a prospective study. Br J Gen Prac 2005, 55:838-845.
14. Danesh J., Wheeler J.G., Hirschfield G.M., et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. NEJM 2004, 350:1387-1397.
15. Lloyd-Jones D.M., Liu K., Tian L., Greenland P. Narrative review: assessment of C-reactive protein in risk prediction for cardiovascular disease. Ann Intern Med 2006, 145:35-42.
16. McNeill A.M., Rosamond W.D., Girman C.J. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care 2005, 28:385-390.
17. Jackson R. Updated New Zealand cardiovascular risk-benefit prediction guide. BMJ 2000, 320:709-710.
18. Pyörälä K., de Backer G., Graham I., et al. Prevention of coronary heart disease in clinical practice: recommendations of the Task Force of the European Society of Cardiology. European Atherosclerotic Society and European Society of Hypertension. Eur Heart J 1994, 15:1300-1331.
19. British Cardiac Society, British Hypertension Society, Diabetes UK, Heart UK, Primary Care Cardiovascular Society, The Stroke Association JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice. Heart 2005, 91(Suppl. V):V1-V52.
20. Haq I.U., Ramsay L.E., Jackson P.R., Wallis E.J. Prediction of coronary risk for primary prevention of coronary heart disease: a comparison on methods. Q J Med 1999, 92:379-385.
21. Wallis E.J., Ramsay L.E., Haq I.U., et al. Coronary and cardiovascular risk estimation for primary prevention: validation of a new Sheffield table in the 1995 Scottish health survey population. BMJ 2000, 320:671-676.
22. Rabindranath K.S., Anderson N.R., Gama R., Holland M.R. Comparative evaluation of the new Sheffield table and the modified joint British societies' coronary risk prediction chart against a laboratory based risk score calculation. Postgrad Med J 2002, 78:269-272.
23. Brindle P., May M., Gill P., et al. Primary prevention of cardiovascular disease: a web-based risk score for seven British black and minority ethnic groups. Heart 2006, 92:1595-1602.
24. Conroy R.M., Pyörälä K., Fitzgerald A.P., et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003, 24:987-1003.
25. Ulmer H., Kollerits B., Kelleher C., et al. Predictive accuracy of the SCORE risk function for cardiovascular disease in clinical practice: a prospective evaluation of 44,649 Austrian men and women. Eur J Cardiovasc Prev Rehabil 2005, 12:433-441.
26. Neuhauser H.K., Ellert U., Kurth B.-M. A comparison of Framingham and SCORE-based cardiovascular risk estimates in participants of the German National Health Interview and Examination 1998. Eur J Cardiovasc Prev Rehabil 2005, 12:442-450.
27. Woodward M., Brindle P., Tunstall-Pedoe H. Adding social deprivation and family history to cardiovascular risk assessment: the ASSIGN score from the Scottish Heart Health Extended Cohort (SHHEC). Heart 2007, 93:172-176.
28. Assmann G., Cullen P., Schulte H. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Münster (PROCAM) study. Circulation 2002, 105:310-315.
29. Empana J.P., Ducimetière P., Arveiler D., et al. Are the Framingham and PROCAM coronary heart disease risk functions applicable to different European populations? The PRIME Study. Eur Heart J 2003, 1903-1911.
30. Cooper J.A., Miller G.J., Humphries S.E. A comparison of the PROCAM and Framingham point-scoring systems for estimation of individual risk of coronary heart disease in the Second Northwick Park Heart Study. Atherosclerosis 2005, 181:93-100.
31. Ridker P.M., Buring J.E., Rifai N., Cook N.R. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. JAMA 2007, 297:611-619.
32. Ridker P.M., Paynter N.P., Rifai N., Gaziano J.M., Cook N.R. C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds risk score for men. Circulation 2008, 118:2243-2251.
33. Hippisley-Cox J., Coupland C., Vinogradova Y., et al. Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study. BMJ 2007, 335:136.
34. Hippisley-Cox J., Coupland C., Vinogradova Y., et al. Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2. BMJ 2008, 336:1475-1482.
35. Hippisley-Cox J., Coupland C., Vinogradova Y., et al. Performance of the QRISK cardiovascular risk prediction algorithm in an independent UK sample of patients from general practice: a validation study. Heart 2008, 94:34-39.
36. Collins G.S., Altman D.G. An independent external validation and evaluation of QRISK cardiovascular risk prediction: a prospective open cohort study. BMJ 2009, 339:b2584.
37. Royal College of General Practitioners Lipid modification: cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease 2008, RCGP, London. http://www.nice.org.uk/Guidance/CG67/Guidance/pdf/English.